Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease

NCT02960503 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Key personnel moved to new location. Therefore, we had insufficient resources to initiate the trial.

Conditions

Interventions

Sponsor

Vanderbilt University